These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 11522385)

  • 21. Recognition of a glycosylation substrate by the O-GlcNAc transferase TPR repeats.
    Rafie K; Raimi O; Ferenbach AT; Borodkin VS; Kapuria V; van Aalten DMF
    Open Biol; 2017 Jun; 7(6):. PubMed ID: 28659383
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional significance of O-GlcNAc modification in regulating neuronal properties.
    Hwang H; Rhim H
    Pharmacol Res; 2018 Mar; 129():295-307. PubMed ID: 29223644
    [TBL] [Abstract][Full Text] [Related]  

  • 23.
    Eustice M; Bond MR; Hanover JA
    Biochem Soc Trans; 2017 Apr; 45(2):427-436. PubMed ID: 28408483
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intracellular and extracellular O-linked N-acetylglucosamine in the nervous system.
    Ogawa M; Sawaguchi S; Kamemura K; Okajima T
    Exp Neurol; 2015 Dec; 274(Pt B):166-74. PubMed ID: 26278182
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tools for probing and perturbing O-GlcNAc in cells and in vivo.
    Cecioni S; Vocadlo DJ
    Curr Opin Chem Biol; 2013 Oct; 17(5):719-28. PubMed ID: 23906602
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insights into O-linked N-acetylglucosamine ([0-9]O-GlcNAc) processing and dynamics through kinetic analysis of O-GlcNAc transferase and O-GlcNAcase activity on protein substrates.
    Shen DL; Gloster TM; Yuzwa SA; Vocadlo DJ
    J Biol Chem; 2012 May; 287(19):15395-408. PubMed ID: 22311971
    [TBL] [Abstract][Full Text] [Related]  

  • 27. O-GlcNAc-specific antibody CTD110.6 cross-reacts with N-GlcNAc2-modified proteins induced under glucose deprivation.
    Isono T
    PLoS One; 2011 Apr; 6(4):e18959. PubMed ID: 21526146
    [TBL] [Abstract][Full Text] [Related]  

  • 28. T cell development and the physiological role of O-GlcNAc.
    Abramowitz LK; Hanover JA
    FEBS Lett; 2018 Dec; 592(23):3943-3949. PubMed ID: 29904918
    [TBL] [Abstract][Full Text] [Related]  

  • 29. O-GlcNAc modification affects the ATM-mediated DNA damage response.
    Miura Y; Sakurai Y; Endo T
    Biochim Biophys Acta; 2012 Oct; 1820(10):1678-85. PubMed ID: 22759405
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Implications of the O-GlcNAc modification in the regulation of nuclear apoptosis in T cells.
    Johnson B; Opimba M; Bernier J
    Biochim Biophys Acta; 2014 Jan; 1840(1):191-8. PubMed ID: 24035784
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Feedback Regulation of
    Lin CH; Liao CC; Chen MY; Chou TY
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33801653
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification and characterization of a missense mutation in the
    Vaidyanathan K; Niranjan T; Selvan N; Teo CF; May M; Patel S; Weatherly B; Skinner C; Opitz J; Carey J; Viskochil D; Gecz J; Shaw M; Peng Y; Alexov E; Wang T; Schwartz C; Wells L
    J Biol Chem; 2017 May; 292(21):8948-8963. PubMed ID: 28302723
    [No Abstract]   [Full Text] [Related]  

  • 33. Genetic recoding to dissect the roles of site-specific protein O-GlcNAcylation.
    Gorelik A; Bartual SG; Borodkin VS; Varghese J; Ferenbach AT; van Aalten DMF
    Nat Struct Mol Biol; 2019 Nov; 26(11):1071-1077. PubMed ID: 31695185
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Critical observations that shaped our understanding of the function(s) of intracellular glycosylation (O-GlcNAc).
    Zachara NE
    FEBS Lett; 2018 Dec; 592(23):3950-3975. PubMed ID: 30414174
    [TBL] [Abstract][Full Text] [Related]  

  • 35. O-GlcNAc transferase inhibitors: current tools and future challenges.
    Trapannone R; Rafie K; van Aalten DM
    Biochem Soc Trans; 2016 Feb; 44(1):88-93. PubMed ID: 26862193
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intracellular protein O-GlcNAc modification integrates nutrient status with transcriptional and metabolic regulation.
    Nagel AK; Ball LE
    Adv Cancer Res; 2015; 126():137-66. PubMed ID: 25727147
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting O-glycosyltransferase (OGT) to promote healing of diabetic skin wounds.
    Runager K; Bektas M; Berkowitz P; Rubenstein DS
    J Biol Chem; 2014 Feb; 289(9):5462-6. PubMed ID: 24398691
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo modulation of O-GlcNAc levels regulates hippocampal synaptic plasticity through interplay with phosphorylation.
    Tallent MK; Varghis N; Skorobogatko Y; Hernandez-Cuebas L; Whelan K; Vocadlo DJ; Vosseller K
    J Biol Chem; 2009 Jan; 284(1):174-181. PubMed ID: 19004831
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modulation of O-linked N-acetylglucosamine levels on nuclear and cytoplasmic proteins in vivo using the peptide O-GlcNAc-beta-N-acetylglucosaminidase inhibitor O-(2-acetamido-2-deoxy-D-glucopyranosylidene)amino-N-phenylcarbamate.
    Haltiwanger RS; Grove K; Philipsberg GA
    J Biol Chem; 1998 Feb; 273(6):3611-7. PubMed ID: 9452489
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nucleocytoplasmic human O-GlcNAc transferase is sufficient for O-GlcNAcylation of mitochondrial proteins.
    Trapannone R; Mariappa D; Ferenbach AT; van Aalten DM
    Biochem J; 2016 Jun; 473(12):1693-702. PubMed ID: 27048592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.